WHAT'S NEW

AT ADMESCOPE

Archive

Rodent lab relocated to new facilities

23 February 2018

Admescope is pleased to announce that we have relocated our rodent lab to new facilities. The new lab being bigger, more modern and better located will increase both our capacity and efficiency. The lab has been equipped with state-of-the-art instrumentation, such as individually ventilated cages together with Scanclime® air handling unit, as well as an anaesthesia system to enable safe conduct of experiments.

“Our in vivo lab was initially opened less than two years ago, and as the demand kept increasing we decided it was time for an upgrade. The new lab has been relocated to allow a complete re-design by our experienced team to maximise the full potential of the new facilities. This will provide us with enough capacity to actively continue our in vivo R&D projects in addition to performing customer studies.” Comments Dr Janne Mannila, Senior scientist Permeability and in vivo DMPK at Admescope.

The new facilities have been accredited by local authorities allowing us to continue providing high-quality rodent DMPK studies, including bioanalysis, completely in-house for our customers around the world. These studies are available using the conventional blood collection method or Mitra® microsampling reducing the number of animals needed in the experiment. Studies with larger laboratory animals are also available through our partner companies located in the EU.

Admescope offers a wide selection of different animal studies for in vivo drug metabolism and pharmacokinetics research ranging from basic PK screening to full evaluation of pharmacokinetic parameters and additional PBPK modelling. Utilising high resolution mass spectrometry for bioanalysis enables us to use the same data for metabolite profiling and identification any time later on.